Emerging effects of comorbidities on multiple sclerosis

Lancet Neurology
Ruth Ann Marrie, Ralph I Horwitz

Abstract

Although the interaction between comorbidities and chronic diseases is strong, the effect of comorbidities receives little attention in many chronic diseases. In multiple sclerosis (MS), an increasing amount of evidence suggests that physical and mental comorbidities, and adverse health factors such as smoking and obesity, are common and can affect the disease. These comorbid diseases and lifestyle factors affect clinical phenotype, the diagnostic delay between symptom onset and diagnosis, disability progression, and health-related quality of life. Future studies of comorbidity and MS should consider comorbidities and health behaviours and should take into account the modifying effects of socioeconomic status, ethnic origin, and cultural factors. Studies of the frequency of comorbidities in patients with MS should be population based, incorporating appropriate comparator groups. These studies should expand the range of comorbidities assessed, and examine how the frequency of comorbidities is changing over time. Further research is needed to answer many other questions about comorbidities and their associations with MS, including the best way to measure and analyse comorbidities to understand these associations.

References

Mar 1, 1988·Neurology·J De Keyser
Apr 1, 1987·Archives of Neurology·R T JoffeZ Horvath
Nov 1, 1994·Neurology·O DevinskyD Luciano
Jan 1, 1994·Neuroepidemiology·G Dean
Nov 13, 1996·JAMA : the Journal of the American Medical Association·C HoffmanH Y Sung
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·M J HoholH L Weiner
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·L D JacobsD H Snyder
May 29, 2000·Brain : a Journal of Neurology·S A BroadleyD A Compston
Aug 16, 2000·Mayo Clinic Proceedings·K KimuraS F Phillips
Jul 5, 2001·Journal of Clinical Epidemiology·R GijsenG A van den Bos
Mar 29, 2002·Annals of Neurology·Maria TrojanoPaolo Livrea
Sep 7, 2002·JAMA : the Journal of the American Medical Association·Evette WeilChristina C Wee
May 3, 2003·Journal of Clinical Epidemiology·Vincent de GrootLex M Bouter
Jun 11, 2003·Journal of Neurology·Gerald NiederwieserJuan J Archelos
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jan 14, 2004·Chest·C Martin TammemagiPaul Kvale
Mar 27, 2004·Annals of Family Medicine·Elizabeth A BaylissDeborah S Main
Jul 14, 2004·American Journal of Public Health·Kyle SteenlandJames Walker
Jul 23, 2004·Expert Opinion on Drug Safety·Gordon Francis
Jan 25, 2005·Current Diabetes Reports·Lenore J Launer
Mar 11, 2005·Brain : a Journal of Neurology·Miguel A HernánHershel Jick
May 10, 2005·Postgraduate Medical Journal·S M LearyA J Thompson
Sep 20, 2005·Journal of Clinical Epidemiology·Julie E BylesCarla Treloar
Oct 12, 2005·Neurology·Scott B PattenLuanne M Metz
Dec 15, 2005·JAMA : the Journal of the American Medical Association·Paula A BravemanSamuel Posner
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Apr 26, 2006·Neurology·R A MarrieD Campagnolo
Jun 6, 2006·Social Psychiatry and Psychiatric Epidemiology·Isabelle BrayJulian Somers
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M PugliattiI Milanov
Jul 19, 2006·Journal of Rehabilitation Research and Development·William J CulpepperDouglas D Bradham
Aug 18, 2006·The New England Journal of Medicine·Meredith MinklerJack M Guralnik
Feb 14, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M Korostil, A Feinstein
Apr 18, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M ManconiL Ferini-Strambi
Jun 22, 2007·Lancet Neurology·Ruth Ann Marrie
Jul 7, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M J Gómez-ChocoA Saiz
Sep 27, 2007·Multiple Sclerosis : Clinical and Laboratory Research·K V L TurpinW J Hader
Oct 19, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M ManconiM Filippi

❮ Previous
Next ❯

Citations

Jul 14, 2012·Current Neurology and Neuroscience Reports·Shannon OversAaron P Turner
Oct 20, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M Schürks, P Bussfeld
Oct 26, 2012·Neuroepidemiology·Ruth Ann MarrieUNKNOWN CIHR Team in the Epidemiology and Impact of Comomrbidity on Multiple Sclerosis
Oct 8, 2013·Acta Neuropathologica·Edward B Lee, Mark P Mattson
Nov 10, 2013·ISRN Neurology·Manolis MarkianosConstantinos Sfagos
Jan 9, 2014·American Journal of Physical Medicine & Rehabilitation·Susan L KasserGianni F Maddalozzo
May 31, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Veronica VillaniLuca Prosperini
Aug 7, 2013·Continuum : Lifelong Learning in Neurology·Ruth Ann Marrie, Heather Hanwell
Aug 12, 2014·Disability and Rehabilitation·Lorraine H De Souza, Andrew O Frank
Oct 2, 2012·Disability and Health Journal·Matthew PlowChi Cho
Oct 7, 2015·Archives of Physical Medicine and Rehabilitation·Lara A Pilutti, Robert W Motl
Jun 29, 2011·Annals of Neurology·Mia L van der KopHelen Tremlett
Oct 2, 2015·Current Treatment Options in Neurology·Nuria Sola-VallsAlbert Saiz
Sep 4, 2013·The International Journal of Neuroscience·Natalia NiedzielaKrystyna Pierzchała
Oct 2, 2014·Acta Neurologica Scandinavica·G DeretziI Tsiptsios
Aug 1, 2015·Current Neurology and Neuroscience Reports·Robert W Motl, Brian M Sandroff
Sep 5, 2015·PeerJ·Michelle PloughmanUNKNOWN Health Lifestyle and Aging with MS Canadian Consortium
Jan 2, 2013·Physiotherapy Canada. Physiothérapie Canada·Michelle PloughmanMark Stefanelli
Mar 6, 2015·Sports Medicine·Martin Langeskov-ChristensenUlrik Dalgas
Dec 11, 2014·Journal of the Neurological Sciences·J FloresT Corona
May 24, 2016·Pharmacoepidemiology and Drug Safety·Tingting ZhangHelen Tremlett
May 25, 2016·Expert Review of Neurotherapeutics·Robert W Motl, Lara A Pilutti
Sep 25, 2012·Medicina clínica·Carlos Hernández-Lahoz, Luis Rodrigo
Aug 10, 2016·Multiple Sclerosis International·Elizabeth M WallackMichelle Ploughman
Feb 4, 2014·Mayo Clinic Proceedings·Dean M Wingerchuk, Jonathan L Carter
Nov 3, 2016·International Journal of MS Care·Matthew A Plow, Meghan Golding
Sep 10, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Mauricio F Farez, Jorge Correale
Aug 17, 2011·Multiple Sclerosis : Clinical and Laboratory Research·R Le BoucP Vermersch
Sep 21, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Inez WensBert O Eijnde
Feb 14, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Ruth Ann MarrieUNKNOWN CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis
Feb 7, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Melinda MagyariPer Soelberg Sørensen
May 28, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Devon S ConwayJeffrey A Cohen
Mar 23, 2013·Physical Therapy·Parminder K Padgett, Susan L Kasser
Apr 29, 2016·PloS One·Valerie A J BlockJeffrey M Gelfand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Related Papers

Continuum : Lifelong Learning in Neurology
M S Freedman
Lancet
Alastair Compston, A J Coles
The New England Journal of Medicine
Jeffrey A CohenTRANSFORMS Study Group
Lancet Neurology
David H MillerOlga Ciccarelli
© 2021 Meta ULC. All rights reserved